• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过负载阳离子表面活性剂的隐形眼镜延长阴离子药物的释放。

Extended delivery of an anionic drug by contact lens loaded with a cationic surfactant.

机构信息

Department of Chemical Engineering, University of Florida, Gainesville, FL 32611, USA.

出版信息

Biomaterials. 2013 Apr;34(11):2814-21. doi: 10.1016/j.biomaterials.2012.12.027. Epub 2013 Jan 19.

DOI:10.1016/j.biomaterials.2012.12.027
PMID:23337326
Abstract

Drug eluding contact lenses can be very effective vehicles for ophthalmic drug delivery, but are incapable of releasing drug for more than a few hours. We propose to optimize the interactions of the polymer matrix of the contact lens with the hydrophobic tails of ionic surfactants to adsorb the surfactant molecules on the polymer with high packing and thus create a high surface charge. Ionic drugs can then adsorb on the charged surfactant coated surfaces with high affinity to reduce the transport rates, leading to extended release. Specifically, we show control release of an anionic drug dexamethasone 21-disodium phosphate from poly-hydroxyethyl methacrylate (p-HEMA) contact lenses by utilizing cationic surfactant (cetalkonium chloride). The partition coefficient of the drug increase exponentially with surfactant loading in the gel in at least qualitative agreement with the Debye-Hückel theory. The drug adsorbs on the surfactant covered polymer, and can also diffuse along the surface with diffusivity lower than that for the free drug, leading to a reduction in the effective diffusivity, which is the weighted combination of the free and surface diffusivities. The addition of surfactant did not impact transparency of lenses, and had additional benefits of increase in wettability and significant reduction in protein absorption. With a surfactant loading of about 10%, the drug release duration was increased from about 2 h to 50 h in 1-day ACUVUE(®) contact lenses, proving the viability of using surfactant for increasing drug release durations.

摘要

药物缓释隐形眼镜可以作为眼科药物输送的有效载体,但只能在几个小时内释放药物。我们提出优化隐形眼镜聚合物基质与离子表面活性剂疏水尾的相互作用,将表面活性剂分子吸附在聚合物上,实现高堆积密度,从而产生高表面电荷。然后,离子药物可以通过高亲和力吸附在带电荷的表面活性剂涂层表面上,从而降低药物传输速率,实现药物的持续释放。具体来说,我们通过利用阳离子表面活性剂(十六烷基三甲基氯化铵)展示了从聚羟乙基甲基丙烯酸酯(p-HEMA)隐形眼镜中控制释放阴离子药物地塞米松 21-磷酸二钠盐。药物在凝胶中的分配系数随表面活性剂负载的增加呈指数增长,至少与 Debye-Hückel 理论定性一致。药物吸附在被表面活性剂覆盖的聚合物上,并且也可以在表面上扩散,扩散率低于游离药物,导致有效扩散率降低,这是自由扩散率和表面扩散率的加权组合。表面活性剂的添加并未影响镜片的透明度,而且还增加了润湿性,显著减少了蛋白质的吸收。在表面活性剂负载量约为 10%的情况下,在 1 天 ACUVUE®隐形眼镜中,药物释放持续时间从大约 2 小时延长至 50 小时,证明了使用表面活性剂来增加药物释放持续时间的可行性。

相似文献

1
Extended delivery of an anionic drug by contact lens loaded with a cationic surfactant.通过负载阳离子表面活性剂的隐形眼镜延长阴离子药物的释放。
Biomaterials. 2013 Apr;34(11):2814-21. doi: 10.1016/j.biomaterials.2012.12.027. Epub 2013 Jan 19.
2
Incorporation of drug particles for extended release of Cyclosporine A from poly-hydroxyethyl methacrylate hydrogels.载药微粒使环孢素 A 从聚羟乙基甲基丙烯酸酯水凝胶中长效释放。
Eur J Pharm Biopharm. 2017 Nov;120:73-79. doi: 10.1016/j.ejpb.2017.08.007. Epub 2017 Aug 18.
3
Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs.用于眼科药物延长递送的含表面活性剂软性隐形眼镜。
Biomaterials. 2009 Feb;30(5):867-78. doi: 10.1016/j.biomaterials.2008.10.032. Epub 2008 Nov 17.
4
Incorporation of polymerizable surfactants in hydroxyethyl methacrylate lenses for improving wettability and lubricity.将可聚合表面活性剂掺入羟乙基甲基丙烯酸酯镜片中,以提高润湿性和润滑性。
J Colloid Interface Sci. 2015 May 1;445:60-68. doi: 10.1016/j.jcis.2014.12.061. Epub 2014 Dec 29.
5
Extended delivery of non-steroidal anti-inflammatory drugs through contact lenses loaded with Vitamin E and cationic surfactants.通过载有维生素 E 和阳离子表面活性剂的隐形眼镜来延长非甾体抗炎药物的释放。
Cont Lens Anterior Eye. 2019 Oct;42(5):546-552. doi: 10.1016/j.clae.2019.04.011. Epub 2019 May 11.
6
Drug and surfactant transport in Cyclosporine A and Brij 98 laden p-HEMA hydrogels.环孢素A和月桂醇聚醚-98负载的聚甲基丙烯酸羟乙酯水凝胶中的药物和表面活性剂转运
J Colloid Interface Sci. 2008 Jun 15;322(2):624-33. doi: 10.1016/j.jcis.2008.02.028. Epub 2008 Feb 29.
7
Formation of Drug-Participating Catanionic Aggregates for Extended Delivery of Non-Steroidal Anti-Inflammatory Drugs from Contact Lenses.药物参与的 CATANIONIC 聚集物的形成用于从隐形眼镜中延长非甾体抗炎药物的释放。
Biomolecules. 2019 Oct 10;9(10):593. doi: 10.3390/biom9100593.
8
Drug loading optimization and extended drug delivery of corticoids from pHEMA based soft contact lenses hydrogels via chemical and microstructural modifications.通过化学和微观结构修饰实现基于聚甲基丙烯酸羟乙酯(pHEMA)的软性隐形眼镜水凝胶中皮质类固醇的药物负载优化及延长药物释放
Int J Pharm. 2015 Jun 20;487(1-2):260-9. doi: 10.1016/j.ijpharm.2015.04.037. Epub 2015 Apr 17.
9
Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.含壳聚糖纳米颗粒的聚甲基丙烯酸2-羟乙酯隐形眼镜作为地塞米松磷酸钠眼部给药系统的合成与表征
Pharm Res. 2016 Jul;33(7):1638-48. doi: 10.1007/s11095-016-1903-7. Epub 2016 Mar 10.
10
Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels.环孢素A从Brij - 97微乳液和载有表面活性剂的聚甲基丙烯酸羟乙酯水凝胶的眼部给药。
Int J Pharm. 2008 Sep 1;361(1-2):222-9. doi: 10.1016/j.ijpharm.2008.05.028. Epub 2008 Jun 3.

引用本文的文献

1
Advances in Therapeutic Contact Lenses for the Management of Different Ocular Conditions.用于治疗不同眼部疾病的治疗性隐形眼镜的进展。
J Pers Med. 2023 Nov 3;13(11):1571. doi: 10.3390/jpm13111571.
2
Interpenetrating Polymer Networks of Poly(2-hydroxyethyl methacrylate) and Poly(N, N-dimethylacrylamide) as Potential Systems for Dermal Delivery of Dexamethasone Phosphate.聚甲基丙烯酸2-羟乙酯与聚(N,N-二甲基丙烯酰胺)互穿聚合物网络作为地塞米松磷酸酯皮肤给药的潜在体系
Pharmaceutics. 2023 Sep 15;15(9):2328. doi: 10.3390/pharmaceutics15092328.
3
Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.
接触镜给药系统在眼科疾病治疗中的应用。
Drug Deliv. 2023 Dec;30(1):2219419. doi: 10.1080/10717544.2023.2219419.
4
Review of Potential Drug-Eluting Contact Lens Technologies.药物洗脱隐形眼镜技术潜力综述
Materials (Basel). 2023 May 11;16(10):3653. doi: 10.3390/ma16103653.
5
A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives.干眼症治疗综述:最新进展、诊断方法及未来展望
Pharmaceutics. 2023 Mar 19;15(3):990. doi: 10.3390/pharmaceutics15030990.
6
Formulation development and evaluation of therapeutic contact lens loaded with ganciclovir.载有更昔洛韦的治疗性隐形眼镜的配方开发和评估。
Int Ophthalmol. 2023 Jul;43(7):2225-2236. doi: 10.1007/s10792-022-02618-6. Epub 2023 Jan 2.
7
Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease.载有褪黑素类似物的隐形眼镜:一种治疗干眼症的有前景的治疗工具。
J Clin Med. 2022 Jun 17;11(12):3483. doi: 10.3390/jcm11123483.
8
Effect of Carbon Chain Length, Ionic Strength, and pH on the In Vitro Release Kinetics of Cationic Drugs from Fatty-Acid-Loaded Contact Lenses.碳链长度、离子强度和pH值对载脂肪酸隐形眼镜中阳离子药物体外释放动力学的影响。
Pharmaceutics. 2021 Jul 10;13(7):1060. doi: 10.3390/pharmaceutics13071060.
9
Advances in Molecularly Imprinted Polymers as Drug Delivery Systems.作为药物递送系统的分子印迹聚合物的进展
Molecules. 2021 Jun 11;26(12):3589. doi: 10.3390/molecules26123589.
10
Review of Contemporary Self-Assembled Systems for the Controlled Delivery of Therapeutics in Medicine.当代用于医学中治疗药物控释的自组装系统综述。
Nanomaterials (Basel). 2021 Jan 21;11(2):278. doi: 10.3390/nano11020278.